Two-Year Clinical Outcome of the TWENTE Trial, a Randomized Controlled Trial Comparing Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients

被引：0

作者：

von Birgelen, Clemens ^{[1
]}

Tandjung, Kenneth ^{[1
]}

Sen, Hanim ^{[1
]}

Basalus, Mounir ^{[1
]}

Louwerenburg, J. Hans ^{[1
]}

Stoel, Martin ^{[1
]}

van Houwelingen, K. Gert ^{[1
]}

Linssen, Gerard ^{[2
]}

Said, Salah ^{[3
]}

Nienhuis, Mark ^{[4
]}

Lowik, Marije ^{[1
]}

van der Palen, Job ^{[5
]}

Verhorst, Patrick ^{[1
]}

de Man, Frits ^{[1
]}

机构：

[1] Thoraxctr Twente, Enschede, Netherlands

[2] Ziekenhuisgrp Twente, Almelo, Netherlands

[3] Ziekenhuisgrp Twente, Hengelo, Netherlands

[4] Streekziekenhuis Koningin Beatrix, Winterswijk, Netherlands

[5] Univ Twente, NL-7500 AE Enschede, Netherlands

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2012年 / 60卷 / 17期

关键词：

D O I：

10.1016/j.jacc.2012.08.056

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：B15 / B15

页数：1

共 50 条

[1] A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients The TWENTE Trial
von Birgelen, Clemens
Basalus, Mounir W. Z.
Tandjung, Kenneth
van Houwelingen, K. Gert
Stoel, Martin G.
Louwerenburg, J. W.
Linssen, Gerard C. M.
Said, Salah A. M.
Kleijne, Miep A. W. J.
Sen, Hanim
Lowik, Marije M.
van der Palen, Job
Verhorst, Patrick M. J.
de Man, Frits H. A. F.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (15) : 1350 - 1361
[2] Two-Year Clinical Outcome of Patients With Bifurcation Lesions Treated With Second-generation Zotarolimus-Eluting Resolute Stents and Everolimus-Eluting Xience V Stents in the Randomized TWENTE Trial
Tandjung, Kenneth
Sen, Hanim
Lam, Ming Kai
Lowik, Marije M.
van Houwelingen, Gert
Stoel, Martin G.
Louwerenburg, Hans W.
de Man, F.
Linssen, Gerard C.
Nijhuis, Rogier
Nienhuis, Mark B.
von Birgelen, Clemens
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B61 - B61
[3] Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting Xience V stents: two-year clinical outcome in the gender-stratified randomized, controlled TWENTE trial
Tandjung, K.
Sen, H.
Lam, M. K.
Stoel, M. G.
De Man, F. H. A. F.
Louwerenburg, J. W.
Linssen, G. C. M.
Nijhuis, R.
Nienhuis, M. B.
Von Birgelen, C.
[J]. EUROPEAN HEART JOURNAL, 2013, 34 : 221 - 222
[4] Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting xience V stents: insights from the gender-stratified, randomized, controlled TWENTE trial
Tandjung, Kenneth
Basalus, Mounir W. Z.
Sen, Hanim
Stoel, Martin G.
van Houwelingen, K. Gert
Louwerenburg, J. W.
de Man, Frits H. A. F.
Linssen, Gerard C. M.
Said, Salah A. M.
Kleijne, Miep A. W. J.
van der Palen, Job
von Birgelen, Clemens
[J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 82 (03) : 396 - 405
[5] Complex Patients Treated With Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents in the Randomized TWENTE Trial: Comparison of 2-Year Clinical Outcome
Sen, Hanim
Lam, Ming Kai
Tandjung, Kenneth
Lowik, Marije M.
Stoel, Martin G.
de Man, Frits H. A. F.
Louwerenburg, J. W.
van Houwelingen, Gert K.
Linssen, Gerard C. M.
Doggen, Carine J. M.
Basalus, Mounir W. Z.
von Birgelen, Clemens
[J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2015, 85 (01) : 74 - 81
[6] Final 5-Year Outcome After Implantation of Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in the Broad Patient Population of the Randomized TWENTE Trial
von Birgelen, Clemens
van der Heijden, Liefke C.
Kok, Marlies M.
van Houwelingen, Gert
Stoel, Martin G.
de Man, Frits H.
Louwerenburg, Hans W.
Linssen, Gerard C.
Tandjung, Kenneth
Basalus, Mounir W.
van der Palen, Job
Lowik, Marije M.
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B232 - B232
[7] A RANDOMIZED COMPARISON OF SECOND-GENERATION ZOTAROLIMUS-ELUTING RESOLUTE STENTS VERSUS EVEROLIMUS-ELUTING XIENCE V STENTS IN REAL-WORLD PATIENTS: 4-YEAR LONG-TERM CLINICAL OUTCOMES OF LISA-ERX TRIAL
Kim, Yisik
Chae, Jei Keon
Yoon, Ji Young
Song, Soo Kyeong
Jung, Lae Young
Lee, Sun Hwa
Lee, Sang Rok
Lee, Kyoung Seok
Ko, Jae Ki
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A51 - A51
[8] Everolimus-Eluting Xience V/Promus Versus Zotarolimus-Eluting Resolute Stents in Patients With Diabetes Mellitus
Park, Kyung Woo
Lee, Joo Myung
Kang, Si-Hyuck
Ahn, Hyo-Suk
Kang, Hyun-Jae
Koo, Bon-Kwon
Rhew, Jay Young
Hwang, Sun Ho
Lee, Sung Yoon
Kang, Tae Soo
Kwak, Choong Hwan
Hong, Bum-Kee
Yu, Cheol Woong
Seong, In-Whan
Ahn, Taehoon
Lee, Han Cheol
Lim, Sang Wook
Kim, Hyo-Soo
[J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (05) : 471 - 481
[9] Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents 2-Year Follow-Up of the Randomized TWENTE Trial
Tandjung, Kenneth
Sen, Hanim
Lam, Ming Kai
Basalus, Mounir W. Z.
Louwerenburg, J. W.
Stoel, Martin G.
van Houwelingen, K. Gert
de Man, Frits H. A. F.
Linssen, Gerard C. M.
Said, Salah A. M.
Nienhuis, Mark B.
Lowik, Marije M.
Verhorst, Patrick M. J.
van der Palen, Job
von Birgelen, Clemens
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (24) : 2406 - 2416
[10] Clinical Outcome of Complex Patients Treated With Second-Generation Zotarolimus-Eluting Resolute vs. Everolimus-Eluting Xience V Stents: Insight From 2-Year Follow-up of TWENTE
Sen, Hanim
Tandjung, Kenneth
Lam, Ming Kai
Basalus, Mounir W.
Stoel, Martin G.
de Man, F.
Louwerenburg, Hans W.
van Houwelingen, Gert
Linssen, Gerard C.
Nienhuis, Mark B.
van der Palen, Job
von Birgelen, Clemens
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B55 - B55

← 1 2 3 4 5 →